L’exentération orbitaire a-t-elle encore sa place en 2019 ?
Arnaud Martel(Université de Sherbrooke), Gilles Poissonnet(Centre Antoine Lacassagne), Lauris Gastaud(Leiden University Medical Center), Corine Bertolotto(Centre Méditerranéen de Médecine Moléculaire), Jacques Lagier(Université Côte d'Azur), M. Hamédani(Hôpital Ophtalmique Jules-Gonin)
Cited by 15
Related Papers
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
|Journal of Clinical Oncology|2018|274
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
|Genes & Development|2011|259
Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
|Cancer Research|2010|126
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
|Cell Death and Differentiation|2021|109